JNJeyakumar Natarajan

Jeyakumar Natarajan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jeyakumar Natarajan has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comprehensive regulatory network construction highlights lncRNA-miRNA-mRNA-TF interactions and key molecular drivers in rheumatoid arthritis

    by Rithika Selvaranganathan, Gowtham Murugesan, Pavithra Nagendran, Jeyakumar Natarajan

    Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent inflammation and progressive joint damage. Although numerous molecular contributors have been reported, the integrated regulatory architecture linking coding and non-coding transcripts remains incompletely defined. This study aimed to construct a multilayer lncRNA-miRNA-mRNA-transcription factor (TF) network to prioritize candidate regulators associated with RA. Publicly available RNA-sequencing datasets from RA and control samples were retrieved from the NCBI Sequence Read Archive. Differential expression analysis was performed using DESeq2. High-confidence miRNA-mRNA interactions were obtained from miRDip, miRNA-lncRNA associations from miRNet, and TF annotations from AnimalTFDB. Functional enrichment analyses were conducted to identify overrepresented biological themes. Network topology and module structure were evaluated in Cytoscape using CytoHubba and MCODE. Integration of interaction datasets identified 179 mRNAs targeted by 93 miRNAs, of which 90 miRNAs were connected to 404 annotated lncRNAs. Twenty-five TFs were incorporated into the regulatory framework. Degree-based analysis highlighted QKI, hsa-miR-497-5p, and KCNQ1OT1 as the most connected nodes within their respective categories. Module detection revealed five densely interconnected sub-networks, indicating coordinated regulatory organization. Several prioritized elements have previously been implicated in immune or inflammatory regulation, supporting the biological relevance of the network. This integrative analysis delineates a comprehensive regulatory landscape of RA and provides a ranked set of candidate molecules for future experimental validation. Among these, CCDC6 was identified as a downregulated gene positioned within a highly connected module and linked to multiple hub miRNAs and lncRNAs, suggesting potential functional importance in RA pathobiology.

  • Open Access

    Unraveling the Biomarker Prospects of High-Altitude Diseases: Insights from Biomolecular Event Network Constructed using Text Mining

    by Balu Bhasuran, Sabenabanu Abdulkadhar, Jeyakumar Natarajan

    High-altitude diseases (HAD), encompassing acute mountain sickness (AMS), high-altitude cerebral edema (HACE), and high-altitude pulmonary edema (HAPE), are triggered by hypobaric hypoxia at elevations above 2,500 meters. These conditions pose significant health risks, yet the molecular mechanisms remain insufficiently understood. In this study, we developed a biomolecular event extraction pipeline integrating supervised machine learning with feature-based and multiscale Laplacian graph kernels to analyze 7,847 curated HAD-related abstracts from PubMed. We extracted over 150 unique biomolecular events including gene expression, regulation, binding, and localization and constructed a weighted, undirected biomolecular event network comprising 97 nodes and 153 edges. Using the PageRank algorithm, we prioritized key biomolecules based on their centrality within the event network. The top-ranked proteins included Erythropoietin (EPO) (0.0163), Vascular endothelial growth factor (VEGF) (0.0148), Hypoxia-inducible factor 1 (HIF-1) alpha (0.0136), Endothelial PAS Domain Protein 1 (EPAS1) and Angiotensin-Converting Enzyme (ACE) (0.0119), Egl nine homolog 1 (EGLN1), Endothelin 1 (ET-1), and 70 kilodalton heat shock protein (Hsp70)(0.0118), all of which play crucial roles in oxygen sensing, vascular remodeling, erythropoiesis, and blood pressure regulation. Subnetwork analysis revealed three major functional clusters centered on hypoxia response, inflammation, and stress adaptation pathways. Our integrative approach demonstrates the utility of large-scale text mining and graph-based analysis to uncover mechanistic insights and prioritize potential biomarkers for high-altitude disease.

  • Open Access

    Literature-Based Discovery (LBD): Towards Hypothesis Generation and Knowledge Discovery in Biomedical Text Mining

    by Balu Bhasuran, Gurusamy Murugesan, Jeyakumar Natarajan

    Biomedical knowledge is growing at an astounding pace with a majority of this knowledge represented as scientific publications. Text mining tools and methods represent automatic approaches for extracting hidden patterns and trends from this semi-structured and unstructured data. In biomedical text mining, literature-based discovery (LBD) is the process of automatically discovering novel associations between medical terms otherwise mentioned in disjoint literature sets. LBD approaches have proven to successfully reduce the discovery time of potential associations that are hidden in the vast amount of scientific literature. The process focuses on creating concept profiles for medical terms such as a disease or symptom and connecting them with a drug and treatment based on the statistical significance of the shared profiles. This knowledge discovery approach introduced in 1989 remains a core task in text mining. Currently, the ABC principle-based two approaches namely open discovery and closed discovery are mostly explored in the LBD process. This review starts with a general introduction about text mining followed by biomedical text mining followed by a brief introduction of the core ABC principle and its associated two approaches open discovery and closed discovery in the LBD process. This review discusses the deep learning applications in LBD by reviewing the role of transformer models and neural networks-based LBD models and their future aspects. Additionally, the potential of Large Language Models in enriching the LBD process is discussed with challenges and solutions and finally reviews the key biomedical discoveries generated through LBD approaches in biomedicine and concludes with the current limitations and future directions of LBD. Received: 1 February 2025 | Revised: 12 May 2025 | Accepted: 30 May 2025 Conflicts of Interest The authors declare that they have no conflicts of interest to this work. Data Availability Statement Data sharing is not applicable to this article as no new data were created or analyzed in this study. Author Contribution Statement Balu Bhasuran: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Resources, Data curation, Writing – original draft, Writing – review & editing, Visualization. Gurusamy Murugesan: Methodology, Validation, Formal analysis, Investigation, Resources, Data curation, Writing – original draft, Writing – review & editing, Visualization. Jeyakumar Natarajan: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Resources, Data curation, Writing – original draft, Writing – review & editing, Visualization, Supervision, Project administration.


  • Open Access

    Anticipating On‐Target and Off‐Target Effects of CRISPR/Cas9 Genome Editing Via a Feedforward Neural Network Model

    by Pavithra Nagendran, Gowtham Murugesan, Jeyakumar Natarajan

    Background: Clustered regularly interspaced short palindromic repeats —CRISPR‐associated protein 9 (CRISPR/Cas9) is a gene editing technology that can deliver highly precise genome editing. However, it is difficult to predict both on‐ and off‐target effects of CRISPR/Cas9, which is essential for ensuring the safety and efficiency of genetic modifications made using this technology.Methods: In this study, we used the SITE‐Seq dataset, which comprises CRISPR targets, to classify sequences for both on‐ and off‐target effects. To evaluate sequence pairs, we built a feedforward neural network (FNN) with 10 fully connected layers and compared its performance with that of other state‐of‐the‐art models.Results: We showed that our FNN model attained an accuracy rate of 0.95, greatly improving prediction reliability for both on‐ and off‐target effects compared with other methods.Conclusion: This work contributes a valuable predictive modeling framework to the field of CRISPR research, addressing both on‐ and off‐target effects in a unified manner, which is an essential requirement for the safe and effective application of genomic editing technologies.


  • Radiogenomic Profiling for Survival Analysis in Gastric Cancer: Integrating CT Imaging, Gene Expression, and Clinical Data

    by Anju R. Nath, Kiruthika Thenmozhi, Jeyakumar Natarajan

    Purpose This study aims to integrate CT (Computed Tomography) radiomic features, gene expression profiles, and clinical data to identify radiogenomic biomarkers and improve overall survival prediction in gastric cancer (GC) patients. Procedures. Quantitative radiomic analysis was performed on 37 GC CT images, alongside gene expression and clinical data, to identify biomarkers associated with overall survival. Tumor segmentation and radiomic feature extraction were followed by Pearson correlation for feature selection. Gene Set Enrichment Analysis (GSEA) identified pathways linking gene expression changes with radiomic features. Regression models were applied to explore the relationships between these pathways, radiomic features, and clinical data in survival prediction. Results A total of 107 radiomic features were extracted, with 46 radiomic features, 1,032 genes, and one clinical feature (age) selected for further analysis. GSEA identified 29 significant KEGG pathways, mainly involving immune, signal transduction, and catabolism pathways. In survival analysis, the SVM model performed best, identifying age, genes CSF1R and CXCL12, and image features ShortRunHighGrayLevelEmphasis and Idn (Inverse Difference Normalized) as independent predictors. Conclusion This study highlights the potential of integrating imaging, genomics, and clinical data for prognosis in GC patients, with identified genes suggesting new radiogenomic biomarker candidates for future evaluation.


  • Open Access

    Advancing brain tumor diagnosis: Deep siamese convolutional neural network as a superior model for MRI classification

    by Gowtham Murugesan, Pavithra Nagendran, Jeyakumar Natarajan

    The timely detection and precise classification of brain tumors using techniques such as magnetic resonance imaging (MRI) are imperative for optimizing treatment strategies and improving patient outcomes. This study evaluated five state‐of‐the‐art classification models to determine the optimal model for brain tumor classification and diagnosis using MRI. We utilized 3064 T1‐weighted contrast‐enhanced brain MRI images that included gliomas, pituitary tumors, and meningiomas. Our analysis employed five advanced classification model categories: machine learning classifiers, deep learning‐based pre‐trained models, convolutional neural networks (CNNs), hyperparameter‐tuned deep CNNs, and deep siamese CNNs (DeepSCNNs). The performance of these models was assessed using several metrics, such as accuracy, precision, sensitivity, recall, and F1‐score, to ensure a comprehensive evaluation of their classification capabilities. DeepSCNN exhibited remarkable classification performance, attaining exceptional precision and recall values, with an overall F1‐score of 0.96. DeepSCNN consistently outperformed the other models in terms of F1‐score and robustness, setting a new standard for brain tumor classification. The superior accuracy of DeepSCNN across all classification tasks underscores its potential as a tool for precise and efficient brain tumor classification. This advance may significantly contribute to improved patient outcomes in neuro‐oncology diagnostics, offering insight and guidance for future studies.


  • Open Access

    Radiogenomic-based prediction of genetic alterations in oncogenic signaling pathways in lung cancer

    by Priyadharshini Jayachandran, Gowtham Murugesan, Jeyakumar Natarajan

    Rationale and objectives: Lung adenocarcinoma, a type of non-small cell lung cancer (NSCLC), originates from the peripheral lung tissue and is the most prevalent histologic subtype, constituting around 40% of cases. Understanding the intricate relationships among the signaling pathways and their changes in lung adenocarcinoma is crucial for developing targeted therapies and personalized treatment. This study aimed to analyze the utility of radiomics in assessing alterations in oncogenic signaling pathways in lung cancer. Materials and methods: We investigated the use of radiomic features extracted from computed topography (CT) scan images of four lung adenocarcinoma patients along with alteration data retrieved from online cancer resource (cBioPortal) to generate radiomic signatures associated with oncogenic specific pathways. The combined dataset was used to identify significant features from the CT images. Results: A total of 3408 radiomics features were extracted from CT images, and most significant features among the five pathways TP53, Hippo, Cell cycle, Myc, and Notch pathways were determined using PyRadiomics. Hypothesis testing identified 161, 91, 105, 89, and 9 radiomics features that significantly differed between alterations and no alterations in the TP53, Hippo, Cell cycle, Myc, and Notch pathways with ROC values of 0.82, 0.78, 0.75, 0.75, and 0.83, respectively. The Hippo pathway radiomic signatures exhibited the strong correlation with Myc and Cell cycle pathways. Conclusion: This study highlights the potential of integrating radiomic features with genetic alteration data to identify significant oncogenic pathways. These findings provide insights that could aid in the development of more precise and effective treatment strategies in precision medicine to enhance our understanding of lung adenocarcinoma.


  • Open Access

    Gut metagenomic analysis of gastric cancer patients reveals Akkermansia, Gammaproteobacteria, and Veillonella microbiota as potential non-invasive biomarkers

    by Anju R. Nath, Jeyakumar Natarajan

    The goal of the study was to investigate the changes in the gut microbiota during the advancement of gastric cancer (GC) and identify pertinent taxa associated with the disease. We used a public fecal amplicon gastric cancer dataset from the Sequence Retrieval Archive (SRA), of patients with GC, gastritis, and healthy individuals. We did sequence pre-processing, including quality filtering of the sequences. Then, we performed a diversity analysis, evaluating α- and β-diversity. Next, taxonomic composition analysis was performed and the relative abundances of different taxa at the phylum and genus levels were compared between GC, gastritis, and healthy controls. The obtained results were subsequently subjected to statistical validation. To conclude, metagenomic function prediction was carried out, followed by correlation analysis between the microbiota and KEGG pathways. α analysis revealed a significant difference between male and female categories, while β analysis demonstrated significant distinctions between GC, gastritis, and healthy controls, as well as between sexes within the GC and gastritis groups. The statistically confirmed taxonomic composition analysis highlighted the presence of the microbes Bacteroides and Veillonella. Furthermore, through metagenomic prediction analysis and correlation analysis with pathways, three taxa, namely Akkermansia, Gammaproteobacteria, and Veillonella, were identified as potential biomarkers for GC. Additionally, this study reports, for the first time, the presence of two bacteria, Desulfobacteriota and Synergistota, in GC, necessitating further investigation. Overall, this research sheds light on the potential involvement of gut microbiota in GC pathophysiology; however, additional studies are warranted to explore its functional significance.


  • Open Access

    Integrated Bioinformatics Analysis Reveals ceRNA Triplet Related to Apoptosis in Gastric Cancer

    by Anju R. Nath, Jeyakumar Natarajan

    Apoptosis is a form of programmed cell death and evading the apoptosis is a milestone in gastric cancer (GC) tumorigenesis. Various RNAs such as miRNA (microRNA), mRNA (messenger RNA), lncRNA (long non-coding RNA), circRNA (circular RNA), play crucial roles in the apoptosis mechanism. In this present study, we aimed to understand the role played by these RNAs in apoptosis in GC. We constructed a ceRNA (competitive endogenous RNA) network using the expression profiles obtained from SRA (Sequence Read Archive) and GEO (Gene Expression Omnibus) datasets. After network construction, the differentially expressed mRNAs were used for gene prioritization. The prioritized genes and the RNAs interacting with them were analyzed to study their role in GC apoptosis. Then, we performed functional and pathway analysis to understand the role played by these genes in gastric cancer. This resulted in 37 miRNA-mRNA interactions, one miRNA-lncRNA interaction, and 17 miRNA-circRNA interactions. The binding site analysis resulted in 10 miRNAs that share common MRE (miRNA Response Elements) among mRNA, lncRNAs, circRNA. Besides, we found 33 miRNA-mRNA-circRNA and two miRNA-mRNA-lncRNA valid interactions. Integration of multiple omics datasets revealed dysregulated genes, including IGF1, MME, CCND2, CDH2, and COL1A1, implicated in GC apoptosis. Functional enrichment analysis highlighted pathways related to apoptosis, with CCND2 emerging as a key player. The integrative methodology has revealed a new potential diagnostic biomarker for the regulation of gastric cancer (GC) apoptosis: the CCND2-miR-141-3p-hsa_circ_0008035 ceRNA triplet. This discovery offers fresh perspectives into the intricate regulatory pathways governing gene expression in GC, promising significant insights into its pathology. Received: 6 January 2024 | Revised: 25 April 2024 | Accepted: 10 May 2024 Conflicts of Interest The authors declare that they have no conflicts of interest to this work. Data Availability Statement The data that support the findings of this study are openly available in NCBI database at https://www.ncbi.nlm.nih.gov/sra; in Gene Expression Omnibus (GEO) at https://www.ncbi.nlm.nih.gov/geo/; in ENCORI from https://academic.oup.com/nar/article/42/D1/D92/1063720?login=false. Author Contribution Statement Anju R. Nath: Conceptualization, Methodology, Data Curation, Writing – original draft, Visualization. Jeyakumar Natarajan: Writing – review & editing, Supervision.